Novo Nordisk semaglutide gets U.S. FDA approval for obesity treatment – Reuters

Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS/Jacob Gronholt-PedersenDenmark’s Novo Nordisk (NOVOb.CO) on Friday said the U.S. Food and Drug Admin… [+1195 chars]

Leave a Reply

Your email address will not be published. Required fields are marked *